Question 1

What was the tested purity of lot MTP10626?

Accepted Answer

Lot MTP10626 (SS-31) tested at 99.039% HPLC purity from Synthesis Peptides, based on 2 Certificates of Analysis indexed by Disclosed Labs.

Question 2

Which lab tested lot MTP10626?

Accepted Answer

Lot MTP10626 was tested by Kovera Labs based on COA data in the Disclosed Labs corpus.

Question 3

Does lot MTP10626 appear on multiple vendors?

Accepted Answer

Yes — lot MTP10626 appears across 2 vendors in the Disclosed Labs corpus, which may indicate a reseller relationship or a recycled COA. The HPLC purity range across these COAs is 99.04%–99.04%.

Question 4

Was lot MTP10626 tested for endotoxin?

Accepted Answer

Yes — lot MTP10626 has at least one COA reporting an endotoxin (LAL) result: PASS. Endotoxin testing (USP <85> / LAL) is a safety panel that matters for injectable compounds.

MTP10626

Cross-vendor collision detected

Tests reported

Vendor	Peptide	Lab	Purity	Tests	Tested
Synthesis Peptides	SS-31	Kovera Labs	99.04%	MSLALUSP<71>HM	—	Detail →Source
Orbitrex Peptides	SS-31	Kovera Labs	99.04%	MSLAL